The microbiota and microbiome in aging: Potential implications in health and age-related diseases

Journal of the American Geriatrics Society

Volumn 63, Issue 4, 2015, Pages 776-781

  Zapata, Heidi J ^a   Quagliarello, Vincent J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

infection; microbiome; older adults

Indexed keywords

RNA 16S;

ACTINOBACTERIA; AGING; ARTICLE; BACTEROIDETES; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; DISEASE PREDISPOSITION; FIRMICUTES; FRAIL ELDERLY; FUNCTIONAL STATUS; HABITAT; HEALTH SURVEY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTESTINE FLORA; LIFESPAN; MICROBIOME; NEXT GENERATION SEQUENCING; NONHUMAN; PROTEOBACTERIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); VAGINA ATROPHY; AGED; COLITIS; DEMOGRAPHY; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY;

AGED; AGING; CLOSTRIDIUM DIFFICILE; COLITIS; DISEASE SUSCEPTIBILITY; FRAIL ELDERLY; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; MICROBIOTA; RESIDENCE CHARACTERISTICS;

EID: 84928419459     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13310     Document Type: Article

References (50)

1. Kruif PD,. Microbe Hunters. Cornwall, NY: Cornwall Press, 1926.
2. Fredericks DN, Relman DA,. Sequence-based identification of microbial pathogens: A reconsideration of Koch's postulates. Clin Microbiol Rev 1996; 9: 18-33.
3. Woese CR, Fox GE,. Phylogenetic structure of the prokaryotic domain: The primary kingdoms. Proc Natl Acad Sci U S A 1977; 74: 5088-5090.
4. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007; 449: 804-810.
5. Petrosino JF, Highlander S, Luna RA, et al. Metagenomic pyrosequencing and microbial identification. Clin Chem 2009; 55: 856-866.
6. Luckey TD,. Introduction to intestinal microecology. Am J Clin Nutr 1972; 25: 1292-1294.
7. Sleator RD,. The human superorganism-of microbes and men. Med Hypotheses 2010; 74: 214-215.
8. Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time. Science 2009; 326: 1694-1697.
9. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
10. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107: 11971-11975.
11. Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011; 108 (Suppl 1): 4578-4585.
12. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-227.
13. Karlamangla A, Tinetti M, Guralnik J, et al. Comorbidity in older adults: Nosology of impairment, diseases, and conditions. J Gerontol A Biol Sci Med Sci 2007; 62: 296-300.
14. Biagi E, Candela M, Fairweather-Tait S, et al. Aging of the human metaorganism: The microbial counterpart. Age (Dordr) 2012; 34: 247-267.
15. Keller JM, Surawicz CM,. Clostridium difficile infection in the elderly. Clin Geriatr Med 2014; 30: 79-93.
16. Yoshikawa TT,. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000; 30: 931-933.
17. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-254.
18. Shaw AC, Goldstein DR, Montgomery RR,. Age-dependent dysregulation of innate immunity. Nat Rev Immunol 2013; 13: 875-887.
19. Holmes C,. Review: Systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol 2013; 39: 51-68.
20. Libby P, Lichtman AH, Hansson GK,. Immune effector mechanisms implicated in atherosclerosis: From mice to humans. Immunity 2013; 38: 1092-1104.
21. Wills M, Akbar A, Beswick M, et al. Report from the second cytomegalovirus and immunosenescence workshop. Immun Ageing 2011; 8: 10.
22. Collino S, Montoliu I, Martin FP, et al. Metabolic signatures of extreme longevity in northern Italian centenarians reveal a complex remodeling of lipids, amino acids, and gut microbiota metabolism. PLoS ONE 2013; 8: e56564.
23. Stehle JR Jr., Leng X, Kitzman DW, et al. Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. J Gerontol A Biol Sci Med Sci 2012; 67: 1212-1218.
24. Chu H, Mazmanian SK,. Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol 2013; 14: 668-675.
25. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
26. Brestoff JR, Artis D,. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 2013; 14: 676-684.
27. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500: 232-236.
28. Heintz C, Mair W,. You are what you host: Microbiome modulation of the aging process. Cell 2014; 156: 408-411.
29. Claesson MJ, Cusack S, O'Sullivan O, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2011; 108 (Suppl 1): 4586-4591.
30. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; 488: 178-184.
31. Poulain M, Pes GM, Grasland C, et al. Identification of a geographic area characterized by extreme longevity in the Sardinia island: The AKEA study. Exp Gerontol 2004; 39: 1423-1429.
32. Santoro A, Pini E, Scurti M, et al. Combating inflammaging through a Mediterranean whole diet approach: The NU-AGE project's conceptual framework and design. Mech Ageing Dev 2014; 136-137: 3-13.
33. Pamer EG,. Fecal microbiota transplantation: Effectiveness, complexities, and lingering concerns. Mucosal Immunol 2014; 7: 210-214.
34. Gough E, Shaikh H, Manges AR,. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
35. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415.
36. Lawley TD, Clare S, Walker AW, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012; 8: e1002995.
37. Brotman RM, Shardell MD, Gajer P, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 2013; 21: 450-458.
38. Hummelen R, Macklaim JM, Bisanz JE, et al. Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS ONE 2011; 6: e26602.
39. Petricevic L, Unger FM, Viernstein H, et al. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2008; 141: 54-57.
40. Sears CL, Garrett WS,. Microbes, microbiota, and colon cancer. Cell Host Microbe 2014; 15: 317-328.
41. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-298.
42. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306.
43. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013; 14: 207-215.
44. Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012; 6: 320-329.
45. Ordovas JM, Mooser V,. Metagenomics: The role of the microbiome in cardiovascular diseases. Curr Opin Lipidol 2006; 17: 157-161.
46. Desvarieux M, Demmer RT, Jacobs DR Jr., et al. Periodontal bacteria and hypertension: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). J Hypertens 2010; 28: 1413-1421.
47. Desvarieux M, Demmer RT, Rundek T, et al. Periodontal microbiota and carotid intima-media thickness: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005; 111: 576-582.
48. Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 2011; 108 (Suppl 1): 4592-4598.
49. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575-1584.
50. Mackowiak PA,. Recycling Metchnikoff: Probiotics, the intestinal microbiome and the quest for long life. Front Public Health 2013; 1: 52.